Christopher Mcguigan - Net Worth and Insider Trading

Christopher Mcguigan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christopher Mcguigan owns 3 companies in total, including Synergy Pharmaceuticals Inc (SGYPQ) , Hepion Pharmaceuticals Inc (HEPA) , and Cardiff Oncology Inc (CRDF) .

Click here to see the complete history of Christopher Mcguigan’s form 4 insider trades.

Insider Ownership Summary of Christopher Mcguigan

Ticker	Comapny	Transaction Date	Type of Owner
SGYPQ	Synergy Pharmaceuticals Inc	2015-07-24	director
HEPA	Hepion Pharmaceuticals Inc	2013-10-07	director
CRDF	Cardiff Oncology Inc	2013-01-14	director

Christopher Mcguigan Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Christopher Mcguigan Ownership Network

Ownership Network List of Christopher Mcguigan

No Data

Ownership Network Relation of Christopher Mcguigan

Christopher Mcguigan Owned Company Details

What does Synergy Pharmaceuticals Inc do?

Who are the key executives at Synergy Pharmaceuticals Inc?

Christopher Mcguigan is the director of Synergy Pharmaceuticals Inc. Other key executives at Synergy Pharmaceuticals Inc include director & Executive Chairman Gary S Jacob , Executive Vice Pres. & CFO Gary G Gemignani , and 10 percent owner Paulson & Co. Inc. .

Synergy Pharmaceuticals Inc (SGYPQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Synergy Pharmaceuticals Inc (SGYPQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Synergy Pharmaceuticals Inc (SGYPQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Synergy Pharmaceuticals Inc (SGYPQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Synergy Pharmaceuticals Inc Insider Transactions

No Available Data

What does Hepion Pharmaceuticals Inc do?

Who are the key executives at Hepion Pharmaceuticals Inc?

Christopher Mcguigan is the director of Hepion Pharmaceuticals Inc. Other key executives at Hepion Pharmaceuticals Inc include Chief Scientific Officer Robert T Foster , Chief Financial Officer John T Cavan , and director & CEO and President Gary S Jacob .

Hepion Pharmaceuticals Inc (HEPA) Insider Trades Summary

Over the past 18 months, Christopher Mcguigan made no insider transaction in Hepion Pharmaceuticals Inc (HEPA). Other recent insider transactions involving Hepion Pharmaceuticals Inc (HEPA) include a net purchase of 8,000 shares made by Peter Wijngaard , and a net purchase of 3,200 shares made by Robert T Foster .

In summary, during the past 3 months, insiders sold 0 shares of Hepion Pharmaceuticals Inc (HEPA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Hepion Pharmaceuticals Inc (HEPA) were sold and 11,200 shares were bought by its insiders, resulting in a net purchase of 11,200 shares.

Hepion Pharmaceuticals Inc (HEPA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Hepion Pharmaceuticals Inc Insider Transactions

No Available Data

What does Cardiff Oncology Inc do?

Who are the key executives at Cardiff Oncology Inc?

Christopher Mcguigan is the director of Cardiff Oncology Inc. Other key executives at Cardiff Oncology Inc include Chief Medical Officer Fairooz Kabbinavar , Chief Scientific Officer Mark Erlander , and Chief Financial Officer James E. Levine .

Cardiff Oncology Inc (CRDF) Insider Trades Summary

Over the past 18 months, Christopher Mcguigan made no insider transaction in Cardiff Oncology Inc (CRDF). Other recent insider transactions involving Cardiff Oncology Inc (CRDF) include a net purchase of 52,950 shares made by Gary W Pace ,

In summary, during the past 3 months, insiders sold 0 shares of Cardiff Oncology Inc (CRDF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cardiff Oncology Inc (CRDF) were sold and 52,950 shares were bought by its insiders, resulting in a net purchase of 52,950 shares.

Cardiff Oncology Inc (CRDF)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cardiff Oncology Inc Insider Transactions

No Available Data

Christopher Mcguigan Mailing Address

Above is the net worth, insider trading, and ownership report for Christopher Mcguigan. You might contact Christopher Mcguigan via mailing address: 9005 Westside Parkway, Alpharetta Ga 30004.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.